All Infection Prevention & Control articles – Page 51
-
NewsNext-gen anti-bacterial and anti-viral surface modification technology inspired by Korean mussels
Researchers have successfully developed a next-generation surface modification technology with anti-bacterial and anti-viral contamination properties.While maximizing the bactericidal effect, a polydopamine layer, combined with an antibiotic, inhibits the adsorption of coronavirus.
-
NewsNanoparticles supercharge vinegar’s old-fashioned wound healing power
New research has resulted in the ability to boost the natural bacterial killing qualities of vinegar by adding antimicrobial nanoparticles made from carbon and cobalt.
-
NewsKoala stress linked to virus infection risk
Researchers have revealed a clear relationship between stress and increased disease risk in koalas in South East Queensland and on the New South Wales North Coast.The study tracked the level of koala retrovirus (KoRV) in groups of captive and wild koalas.
-
NewsYeast in gut microbiome can worsen salmonella infection
Researchers have discovered that a yeast commonly found in our gut can make infection with salmonella worse. Salmonella binds to Candida albicans and triggers a chain reaction that allows the bacteria to better invade cells lining the intestines.
-
NewsStudy identifies hotspots of disease-carrying ticks in Illinois
Scientists analyzed the distribution of three potentially harmful tick species in Illinois, identifying regions of the state with higher numbers of these ticks and, therefore, at greater risk of infection with multiple tick-borne diseases.
-
News‘We need to prepare for a growing number of West Nile virus infections,’ experts warn
Growing numbers of West Nile virus infection cases, fueled by climate change, are sparking fears among healthcare providers in Europe. A clinical insight aims to equip medical professionals with the knowledge needed to recognize and manage this emerging disease.
-
NewsScientists discover powerful new antibiotic class to tackle deadly superbugs
Scientists have discovered Novltex, a new class of antibiotics with potent activity against some of the world’s most dangerous multidrug-resistant (MDR) bacteria. It targets lipid II — an essential building block of bacterial cell walls that does not mutate.
-
NewsGuangdong faces largest chikungunya outbreak on record
Guangdong Province is experiencing the largest outbreak of chikungunya fever ever recorded in China, with more than 4,000 confirmed cases since late July. Shunde District of Foshan alone has reported over 3,600 infections, a new paper reports.
-
NewsTuberculosis vulnerability of people with HIV: a viral protein implicated
Tuberculosis accounts for one in three deaths among people living with HIV. A new study highlights the key role played by Tat 2 – a viral protein secreted by HIV-infected cells – in this hyper-vulnerability phenomenon.
-
NewsPlant-derived compound has antimicrobial and anti-inflammatory effects against periodontal disease
Morin-based powder, extracted from guava leaves, apple peel, and figs, can be slowly released with the help of polymers and serve as an alternative to antibiotics.
-
NewsGut infections often overlooked in men who have sex with men
It’s time to develop more effective ways to control and prevent sexually transmitted gut infections, urge the authors of an article that discusses discuss several sexually transmitted enteric pathogens that have become extremely multi-drug resistant.
-
NewsMajor report tackles Covid’s cardiovascular crisis head-on
Regular Covid vaccinations should continue worldwide to reduce cardiac risks associated with the virus - according to new research.
-
NewsStudy recommends integrated risk assessment for zoonotic and vector-borne diseases
A summary of published studies on the risk of emerging diseases shows that only 7.4% simultaneously consider hazard, exposure, and vulnerability to infection.
-
NewsScientists identify four ways our bodies respond to COVID-19 vaccines
Researchers tracked individuals’ antibody levels after vaccinations and identified four distinct patterns of immune response after the first booster, suggesting that monitoring how antibody levels change over time could assist in identifying individuals at greater risk of infection.
-
NewsHow HIV enters the genome – researchers identify previously unknown mechanism
Researchers have decoded a previously unknown mechanism by which HIV-1 selects its integration targets in the human genome. A research team identified RNA:DNA hybrids (R-loops) as molecular signposts for the virus.
-
NewsBout of cystitis may signal presence of urogenital cancers in middle-aged adults
A bout of the common bladder infection, cystitis, may signal the presence of urogenital cancers—which affect parts of the body involved in reproduction and excretion—in middle aged adults, suggests research. The risks seem to be especially high within 3 months of infection.
-
NewsNew Center of Excellence to respond to the challenge of antibiotic-resistant bacteria
Boston Children’s Hospital and Tulane University have received $25 million in funding from NIAID/NIH to establish a Center of Excellence for Translational Research (CETR) called IMPACT (Immunization against Multidrug-resistant Pathogens: Activating T Cell Immunity).
-
NewsU.S. Public Health Service releases new guidelines on occupational HIV exposure and postexposure prophylaxis
The CDC, on behalf of the U.S. Public Health Service (PHS), has released the 2025 Guidelines for the Management of Occupational Exposure to Human Immunodeficiency Virus (HIV) and Recommendations for Postexposure Prophylaxis (PEP).
-
NewsType 2 diabetes may double risk of sepsis, large community-based study suggests
Living with type 2 diabetes (T2D) may double the risk of developing sepsis—with those aged younger than 60 years and men particularly susceptible, according to a long-term community-based study in Australia.
-
NewsScientists link waning Japanese encephalitis immunity to higher dengue severity
Scientists have found that waning immunity to Japanese encephalitis virus (JEV) may increase the risk of more severe dengue disease in humans. The study highlights how fading vaccine protection from one virus can unintentionally affect the body’s response to another.